Scientists could be a step closer to identifying and treating early cases of lupus, before the onset of organ-damaging illness.
News & Stories
Dr. Diane Kamen of the Medical University of South Carolina provides an overview of how lupus can affect the body's organs.
The development of a single test that can simultaneously measure several different autoantibodies important in lupus could be important and useful.
The results of this study highlight the important role of lupus anticoagulant, as well as that of a previous blood clot, in adverse pregnancy outcomes.
This study examined the relationship between levels of vitamin D and autoantibodies in people with lupus.
Dr. Deborah McCurdy and Dr. Ornella Rullo found that high levels of a protein called osteopontin may be a predictor of future lupus disease activity and organ damage.
For years, researchers have investigated the possibility of inhibiting the actions of lupus-related autoantibodies to reduce the extent of organ damage. Further research in this area has the potential to facilitate the development of new therapies for people with lupus.
Dr. Joseph McCune of the University of Michigan discusses the role interferon and endothelial cells, which line blood vessels, as possible causes of increased risk of heart attacks and strokes associated with lupus.
Neuropsychiatric lupus (NPSLE) is difficult to diagnose and can be present when disease activity in other organs cannot be identified. The researchers hoped to learn whether antibodies to ganglioside M1 could predict childhood NPSLE any better than standard laboratory measures currently in use.
The researchers hoped to learn whether measurement of C3d and C4d would be a more accurate way to test for lupus disease activity when measured while attached to a red blood cell than when they are freely circulating in the blood.
Some people have antiphospholipid syndrome without other forms of lupus, called primary antiphospholipid syndrome (PAPS). The researchers hoped to learn whether people with systemic lupus or PAPS had different amounts of TNF-α and sIL-2R in their blood.
The researchers wanted to find out if any proteins in the blood could be used to diagnose CNS lupus.
Our Annual Lupus Symposium in Augusta has moved to March 22, 2014!